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AbstrACt
Introduction Antimicrobial resistance is a significant 
worldwide problem largely driven by selective pressure 
exerted through antibiotic use. Preserving antibiotics 
requires identification of opportunities to safely reduce 
prescriptions, for example in the management of mild 
common infections in the community. However, more 
information is needed on how infections are usually 
managed and what proportion lead to consultation 
and antibiotic use. The aim of this study is to quantify 
consultation and prescribing patterns in the community for 
a range of common acute infection syndromes (respiratory, 
gastrointestinal, skin/soft tissue, mouth/dental, eye and 
urinary tract). This will inform development of interventions 
to improve antibiotic stewardship as part of a larger 
programme of work, Preserving Antibiotics through Safe 
Stewardship.
Methods and analysis This will be an online prospective 
community cohort study in England. We will invite 
19 510 adults who previously took part in a nationally 
representative survey (the Health Survey for England) 
and consented to be contacted about future studies. 
Adults will also be asked to register their children. Data 
collection will consist of a baseline registration survey 
followed by weekly surveys sent by email for 6 months. 
Weekly surveys will collect information on symptoms of 
common infections, healthcare-seeking behaviour and use 
of treatments including antibiotics. We will calculate the 
proportions of infection syndromes that lead to General 
Practitioner consultation and antibiotic prescription. We 
will investigate how healthcare-seeking and treatment 
behaviours vary by demographics, social deprivation, 
infection profiles and knowledge and attitudes towards 
antibiotics, and will apply behavioural theory to investigate 
barriers and enablers to these behaviours.
Ethics and dissemination This study has been given 
ethical approval by the University College London Research 
Ethics Committee (ID 11813/001). Each participant 
will provide informed consent upon registration. We 
will disseminate our work through publication in peer-
reviewed academic journals. Anonymised data will be 
made available through the UK Data Service (https://www. 
ukdataservice. ac. uk/).
IntroduCtIon
The emergence of antimicrobial resistance 
(AMR) is a significant worldwide problem. It 
is largely driven by selective pressure exerted 
through antibiotic use and has led to some 
infections becoming untreatable with existing 
antimicrobials.1 Preserving antibiotics for the 
future depends on achieving a safe balance 
between potential population harms of 
prescribing antibiotics and risks to the indi-
vidual of not prescribing. The set of actions 
that promote this responsible use of antibi-
otics is referred to as antibiotic stewardship.2 
Improving stewardship requires identi-
fication of opportunities to safely reduce 
prescriptions of antibiotics. Although 
strengths and limitations of this study
 ► This study will use a novel and efficient method for 
large-scale collection of information about symp-
toms and related healthcare-seeking behaviours.
 ► It will address an important aspect of primary care 
(antibiotic use) by collecting data on a comprehen-
sive set of symptoms of common infections, but will 
not cover sexually transmitted infections.
 ► Collecting data over an entire year will allow season-
al variations to be explored.
 ► Participants will be recruited from a sample that 
is representative of the population living in private 
households in England.
 ► The prospective community cohort design will en-
able information to be captured about symptoms 
irrespective of medical consultation.
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overprescribing of antibiotics for patients presenting at 
primary care with common infections has been widely 
reported,3 there is also evidence for a significant clinical 
‘iceberg’ of infection.4 5 For example, previous studies 
have shown that most patients safely manage respiratory 
and gastrointestinal symptoms without consulting their 
General Practitioner (GP) or taking an antibiotic.4 5 This 
suggests that inappropriate antibiotic prescriptions could 
be reduced through improved management of common 
infections and associated symptoms in the community. 
There is limited information, however, on how the public 
manage symptoms of other infections, what proportion of 
infections lead to consultation and antibiotic use, or how 
these rates vary according to type of symptoms or patient 
characteristics. Establishing this requires information 
to be captured on patients in the community, including 
those who do not seek healthcare, and identification of 
healthcare-seeking behaviours, ideally through prospec-
tive follow-up.
The aim of the Bug Watch study is to quantify consul-
tation and antibiotic prescribing patterns in the commu-
nity for a range of acute common infections (respiratory, 
gastrointestinal, skin/soft tissue, mouth/dental, eye and 
urinary tract). Bug Watch is part of a larger programme 
of work, Preserving Antibiotics through Safe Stewardship 
(PASS), which aims to inform the development of multi-
faceted behavioural interventions that will strengthen 
antibiotic stewardship across a range of healthcare 
settings. Results from Bug Watch will be synthesised with 
insights from qualitative interviews to identify opportuni-
ties for improved antibiotic stewardship in the commu-
nity and general practice and inform development of 
interventions.
MEthods And AnAlysIs
study design and setting
This will be an online prospective community cohort study 
in England. Data collection will consist of a baseline regis-
tration survey followed by weekly surveys for 6 months. 
Weekly surveys will collect information on symptoms of 
common infections, healthcare-seeking behaviour and 
use of treatments including antibiotics.
recruitment
We will recruit participants through the Health Survey for 
England (HSE). HSE is an annual survey first conducted 
in 1991 that monitors changes in the health and life-
styles of people living in England.6 It is commissioned by 
National Health Service (NHS) Digital and run by NatCen 
Social Research and the University College London 
(UCL) Research Department of Epidemiology and Public 
Health. The sample of individuals included in HSE each 
year is designed to be representative of the population 
living in private households in England. Full details of the 
methods for HSE sample have been described previously.7
We will invite all adults who took part in the HSE in 
2013, 2014 or 2015 and who consented to be contacted 
about future research studies (with the exception of 
adults aged 50–53 years from the 2015 survey who were 
recruited to a different study). This comprises 19 510 
adults, of whom we estimate 15 819 (81%) will still be resi-
dent at the address on record when they are contacted. 
Parents or guardians will be invited to register up to four 
children aged under 16, and all information for chil-
dren will be reported by the adult who registered them. 
Anyone aged 16 or over living in the same household will 
be invited to register separately.
As this is a largely descriptive study, and the primary 
outcome is calculation of rates, we did not require a formal 
power calculation. Based on their experience of previous 
population surveys, NatCen estimated that approximately 
25% of those who received a letter would sign up (~4000), 
and approximately 50% of those who signed up would 
complete follow-up (~2000 people completing 6 months 
of follow-up). This would equate to approximately 1000 
person-years of follow-up, which would allow calculation 
of crude rates of 500 cases per 1000 person-years with a 
95% CI of 457 to 546; 200 cases per 1000 person-years, 
95% CI 173 to 230; and 100 cases per 1000 person-years 
95% CI 81 to 122.
Recruitment will be conducted in four waves starting 
in March, June, September and November 2018. Initial 
invitations to take part in Bug Watch will be sent by post. 
Those who wish to sign up will be directed to a web link. 
A second reminder letter will be sent to those who have 
not registered approximately 3 weeks after the initial invi-
tation was sent. Where possible, invitation reminders will 
also be sent by email or SMS text message. Individuals 
who are invited and do not wish to take part in the study 
will be removed from contact lists.
Participant materials and incentives
The initial invitation letter will include a participant 
information sheet which will describe the purpose of 
the study, what participants will be asked to do and the 
contact details of the study team. It will also include a 
paper copy of a ‘symptom diary’, which will be designed 
to help participants to keep track of the symptoms of 
infection that will be collected in the weekly surveys.
Study invitations will direct those interested in partic-
ipating to a UCL web page. This page will include the 
registration survey URL as well as a short video describing 
the study. Those wishing to register children will also be 
able to download an information sheet for children. We 
will design this sheet so that it is suitable to be read by 
anyone aged approximately 8 years or older. Following 
registration, participants will be sent a reusable lami-
nated copy of the symptom diary, a pen and a Bug Watch-
branded magnet.
During follow-up, participants will be sent two email 
newsletters. These newsletters will provide updates about 
the study such as rates of weekly survey completion. To 
avoid influencing the behaviour of participants during 
follow-up, the newsletters will not include details about 
the main study outcomes.
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All participants will receive a £5 voucher to thank them 
for registering. At the end of follow-up, those who have 
completed at least 50% of their weekly surveys will be 
sent an additional £5 voucher to thank them for partici-
pating. They will also be entered into a prize draw to win 
a further £50 voucher.
data collection
All data will be collected using Research Electronic Data 
Capture (REDCap) electronic data capture tools hosted 
on the UCL Data Safe Haven.8 REDCap is a secure, 
web-based application for research studies. The UCL 
Data Safe Haven provides a technical solution for storing, 
handling and analysing identifiable data. It has been 
certified to the ISO27001 information security standard 
and conforms to NHS Digital’s Information Governance 
Toolkit. Data analysis will also be conducted within the 
UCL Data Safe Haven, from which personal information 
will not be removed.
Online registration will take approximately 15 min/
person. Participants will be asked to provide consent, 
confirming that they have read and understood the infor-
mation sheets. Parents or legal guardians will be asked to 
give formal consent for children under the age of 16. For 
children that are able to give assent, the parent or legal 
guardian will be asked to discuss with them whether they 
wish to take part or not. Consent for linking data to the 
broader HSE survey data and for contact for qualitative 
interviews will also be requested.
Full details of the baseline data collection are shown in 
table 1. The baseline survey will collect information on 
contact details, demographics, household composition, 
general health, oral health and GP consultations. It will 
also include questions about knowledge and attitudes 
towards antibiotics, adapted from Wave 3 of the Wellcome 
Trust Monitor survey, and the EQ-5D-3L instrument for 
measuring health-related quality of life.9 10 The Wellcome 
Table 1 Baseline data collection
Section Fields included
Consent  ► Consent to participate in Bug Watch (required).
 ► Permission to be contacted for qualitative interviews; for data to be linked to the Health Survey for 
England; to be contacted about a urinary tract infection substudy (optional).
Contact details  ► ID number (from invitation letter).
 ► Name.
 ► Email address.
 ► Postal address.
Demographics  ► Date of birth.
 ► Sex.
 ► Country of birth.
 ► Ethnic group.
 ► Work status (employed, in education, unemployed, retired and so on).
 ► Full or part time work.
 ► Is a healthcare worker.
General health  ► Long term illnesses or health problems.
 ► Recurrent urinary tract infections.
 ► Currently pregnant; which trimester.
 ► Smoking status.
 ► Seasonal influenza vaccine in the last year.
 ► EQ-5D-3L.
GP consultations  ► Number of GP consultations in last 12 months.
Antibiotics  ► Ever been prescribed antibiotics; number in last 12 months.
 ► Ever been prescribed antibiotics but thought it was not the right treatment.
 ► When last took antibiotics; were they prescribed (if not, where from); were all taken.
 ► Ever asked for an antibiotic prescription; was it given; needed to persuade.
 ► Which conditions think can be treated with antibiotics.
 ► Understanding of term ‘antibiotic resistance’.
Oral health  ► Rate dental health (global item).
 ► Has dentures.
 ► Dental symptoms in last 12 months.
 ► Problems caused by mouth/teeth/ dentures in last 12 months (impact on quality of life).
Household 
composition
 ► Number of adults (aged 16+).
 ► Number of children, number to be registered (up to 4).
NB, Questions are filtered and adapted based on previous responses so that they are only shown to participants when relevant. For example, 
‘Currently pregnant’ is not shown if sex is given as male. GP, General Practitioner.
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Trust Monitor survey is designed to be representative of 
the UK adult population and measures trends in public 
attitudes towards science. Wave 3 of the survey, conducted 
in 2015, included a set of questions about knowledge 
and attitudes towards antibiotics. The EQ-5D-3L is a 
standardised measure of health status developed by the 
EuroQol Group that provides a simple, generic measure 
of health for clinical and economic appraisal.10
On the first Monday after registration, participants will 
be sent an email reminding them to start keeping track 
of symptoms of infection. Following this, they will be sent 
weekly emails each Monday with a link to a survey to fill in 
details about symptoms from the previous 7 days and how 
they managed them. These emails will be sent each week 
for 6 months, and each survey will be open for 1 week. 
One reminder email will be sent on the Thursday of each 
week if the survey has not been completed. Participants 
will be given the opportunity to complete feedback forms 
about Bug Watch after approximately 6 weeks of partici-
pation, and again after all weekly surveys have been sent.
The symptoms that will be monitored in Bug Watch are 
shown in table 2. For each day that a symptom is reported, 
participants will be asked to rate its severity (mild, 
moderate or severe) and to complete the EQ-5D-3L. 
They will also be asked to report what they did about their 
symptoms including whether they took time off work (or 
school), sought medical advice, or took any treatments. 
When antibiotics are reported, further details will be 
collected about the type of antibiotic, duration, who it was 
prescribed by (or how otherwise obtained) and adher-
ence to treatment.
At the end of a series of symptoms, participants will be 
asked to complete a set of questions about what influ-
enced how they managed their symptoms, specifically 
whether or not they consulted their GP and sought anti-
biotics. We will apply the Capability, Motivation, Oppor-
tunity, Behaviour (COM-B) model of behaviour change, 
which has been validated for studies of the general popu-
lation,11 to explore the wide-range of potential individual, 
sociocultural and environmental barriers/enablers to 
these behaviours. The survey will include at least one 
item mapping onto each domain of the COM-B model 
(table 3). Items will be in the form of belief statements 
to which participants rate their agreement on Likert-type 
scales from 1—Strongly Disagree to 5—Strongly Agree.
In all surveys, we will make use of ‘skip logic’ to ensure 
that participants are only shown questions that are rele-
vant to them. For example, they will first be asked if they 
have any symptoms, and only if they do will they be shown 
specific symptom categories. Weekly surveys will there-
fore take no longer than a minute if no symptoms are 
reported, and approximately 5–10 min if symptoms are 
reported.
statistical analysis
We will describe the demographic characteristics of the 
Bug Watch cohort and assess its representativeness by 
comparing with the characteristics of the broader HSE T
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sample and published national statistics. We will also 
assess the representativeness of the knowledge and atti-
tudes towards antibiotics of the cohort by comparing with 
the Wellcome Trust Monitor Survey.9
Symptoms reported will be combined into infection 
syndromes (ie, combinations of symptoms associated 
with an episode of infection). We will create descrip-
tive profiles of infection syndromes including types of 
symptom reported, duration, timing and severity. We 
will calculate the proportions of infection syndromes 
that lead to people consulting their GP and receiving 
antibiotics. Antibiotic use will be described in terms of 
type of antibiotic, duration, who it was prescribed by (or 
how otherwise obtained) and adherence to treatment. 
Other healthcare-seeking behaviours, behavioural influ-
ences (barriers and enablers within the COM-B model) 
and treatments taken to manage symptoms will also be 
described.
We will use Poisson regression to calculate rates of 
infection, consultation and antibiotic prescribing. 
These analyses will be weighted by the population struc-
ture of England (age, sex, index of multiple depriva-
tion, region—as indicted by representativeness) and 
will account for the clustered nature of the data. We will 
use logistic regression to investigate how GP consulta-
tion and antibiotic prescribing varies by age, gender, 
ethnicity, presence of other illnesses, social deprivation, 
infection syndrome and knowledge and attitudes towards 
antibiotics. Continuous variables will be converted into 
categorical variables. We will also assess the impact of 
different types of infection on quality of life using the 
EQ5D-3L scores, and on reported work and school 
absences. We will use these measures to estimate the 
overall impact of community infection at the population 
level. Full statistical methods will be presented with rele-
vant analyses.
Patient and public involvement
Participants were not directly involved in design of this 
study although feedback will be collected at two time points 
during follow-up. Newsletters will be sent to give participants 
updates during the study, and a summary of the main find-
ings will be available at the end. As part of the wider PASS 
study, a subset of participants will be invited to take part in 
qualitative interviews that will draw on behavioural theory to 
investigate the drivers of healthcare-seeking behaviours (full 
methods will be published elsewhere). Findings from Bug 
Watch and the related interviews will inform stakeholder 
panels to develop stewardship interventions through a 
user-centred design approach.
Ethics and dissemination
Each participant will provide informed consent on regis-
tration. We will disseminate our work through publica-
tion in peer-reviewed academic journals and presentation 
at conferences. Findings will contribute to interventions 
and educational materials developed through the wider 
PASS study. Anonymised data from Bug Watch will be 
made available through the UK Data Service (https://
www. ukdataservice. ac. uk/) for use by other researchers.
Author affiliations
1Institute of Health Informatics, University College London, London, UK
2NatCen Social Research, London, UK
3Centre for Behaviour Change, University College London, London, UK
4Department of Epidemiology and Public Health, University College London, London, 
UK
5Population Health Science Institute, University of Bristol, Bristol, UK
6Institute of Epidemiology and Health Care, University College London, London, UK
7Faculty of Epidemiology & Population Health, London School of Hygiene and 
Tropical Medicine, London, UK
Contributors Written on behalf of the Preserving Antibiotics through Safe 
Stewardship (PASS) study research group. CMS is responsible for data collection, 
management and analysis, and drafted the protocol. AH, EBF and the PASS study 
Table 3 Example items exploring barriers/enablers to GP consulting and antibiotic seeking behaviours, based on the COM-B 
model of behaviour change11 (asked at the end of a series of symptoms in Bug Watch)
COM-B domain Example barrier/enabler belief statements
Capability (psychological) ‘I thought antibiotics would be effective in treating my symptoms’
‘I did not know what other treatments were available’
Capability (physical) ‘I felt too unwell to travel to the GP practice’
Opportunity (social) ‘I was encouraged by others to go see my GP’
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‘I was involved in the decision of whether or not to take antibiotics’
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COM-B, Capability, Motivation, Opportunity, Behaviour; GP, General Practitioner.
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